NR

Narayana Reddy Yarraguntla

Active Director Director DIN 02809282
DIN 02809282 First appointment Jun 2001 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2001
Shareholding value β€’β€’β€’β€’ Premium profile

About Narayana Reddy Yarraguntla

Data last updated:

Narayana Reddy Yarraguntla is a Director at Lamrin Medisys Private Limited (since 2001). The company operates in Chemicals and Materials.

DIN 02809282
Primary Designation Director
Industry Chemicals and Materials
First Appointment 19 Jun 2001
Oldest Company Age 25 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lamrin Medisys Private Limited U24230TG2001PTC036898
Director19 Jun 20012001Active

Board colleagues of Narayana Reddy Yarraguntla

NameDINCompanyDesignation
Nirmala Yerraguntla02809283Lamrin Medisys Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lamrin Medisys Private Limited
Premium access

Shareholding and investment profile for Narayana Reddy Yarraguntla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Narayana Reddy Yarraguntla

Narayana Reddy Yarraguntla currently holds 1 directorship: Lamrin Medisys Private Limited (Director, since 19 Jun 2001).

Narayana Reddy Yarraguntla was first appointed on 19 Jun 2001 as Director at Lamrin Medisys Private Limited.

The current boards of Narayana Reddy Yarraguntla's companies include Nirmala Yerraguntla (Lamrin Medisys Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available